European stockmarkets poised to race ahead
European stockmarkets are being tipped to outperform the US for the rest of the year, and into next year too.
“Global investors have had little love for Europe in the past decade,” says Nicholas Jasinski in Barron’s. “Anaemic” growth and political instability “have kept a lid on European stocks”. Yet with reopening gathering pace, “the near-term case for relative outperformance by Europe now is the strongest in years”. The pan-European Stoxx 600 index ended the first half of the year last week with a 13.5% gain.
Pack your vaccine passport
Last week the EU launched its vaccine passport, providing a shot in the arm for the tourism industry ahead of the summer season. Brussels and London are working on mutual recognition of the NHS Covid Pass. More than half of the EU’s population has now received at least one dose of a Covid-19 vaccine, with countries such as Germany, the Netherlands and Spain currently outstripping the US on this measure.
European data has surprised on the upside recently, says a Morgan Stanley note. The European Commission’s economic sentiment indicator is at a 21-year high. The US has now passed through the fastest phase of its recovery and there is nervousness about the outlook for monetary policy, says Jasinski. By contrast, Europe’s recovery is only just starting. Indeed, it is “one of the few developed regions” tipped to “see better GDP gains in 2022 than in 2021”. On 16.5 times 2022 earnings the Stoxx 600 is also a welcome remedy for US “valuation vertigo”.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Most investment banks are tipping European markets to outperform the US for “the remainder of the year and into 2022”, says Elliot Smith for CNBC. US fund flows into European stocks so far this year have been the strongest in six years. BNP Paribas’s strategists think easy monetary policy and a broad-based recovery will benefit Europe’s numerous value stocks: the banks, carmakers and energy companies that have been left behind as US tech has soared over the past decade. European shares look well-placed to benefit from the next stage of the recovery, agrees David Brenchley in The Times. Sectors “such as payments, medical technology and green energy” also look promising.
The bull case for Europe extends beyond reopening, says Graham Secker in the Financial Times. Europe’s post-pandemic recovery fund, which has seen member states issue joint bonds for the first time, is a “game-changer”. The fund’s slow rollout has drawn unfavourable comparisons with the much bigger US fiscal stimulus. But while America has created a short-term consumption surge, the European plan is “more focused on longer-term investment” in areas such as digitalisation and provides extra help to weaker peripheral economies. The five-year time horizon should also mean it provides a more consistent tailwind for European equities in the coming years.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
Taiwan Semiconductor shares jump on AI outlookTSMC, Nvidia’s key supplier, has beaten on earnings and poured cold water on talk of an AI bubble
-
Zoopla: Number of homes on sale at eight-year peak – but demand lagging behind 2025The average number of homes listed for sale per estate agent at the start of the year breached 30, property portal Zoopla said
-
The rise and fall of Nicolás Maduro, Venezuela's ruthless dictatorNicolás Maduro is known for getting what he wants out of any situation. That might be a challenge now
-
Polar Capital: a cheap, leveraged play on technologyPolar Capital has carved out a niche in fund management and is reaping the benefits
-
Vaccines inject billions into Big Pharma – how to profit from the sectorThe vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Here's what it means for investors
-
'Investors should keep putting their trust in investment trusts'Interview Peter Walls, manager of the Unicorn Mastertrust fund, analyses investment trusts in a conversation with Andrew Van Sickle
-
Monks Investment Trust is worthy of the spotlightMonks Investment Trust, a global growth trust, sits in the shadow of its stablemate, Scottish Mortgage. But its record warrants attention, says Max King
-
New year, same market forecastsForecasts from banks and brokers are as bullish as ever this year, but there is less conviction about the US, says Cris Sholto Heaton
-
'Expect more policy U-turns from Keir Starmer'Opinion Keir Starmer’s government quickly changes its mind as soon as it runs into any opposition. It isn't hard to work out where the next U-turns will come from
-
Why does Donald Trump want Venezuela's oil?The US has seized control of Venezuelan oil. Why and to what end?